SCHEMBL1084792

SCHEMBL1084792

Cc1cc(CN(C)c2nc(-c3ccccc3O)nc3cc(Cl)ccc23)on1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.46
CYP3A4 P08684 8/20 0.46
CYP2D6 P10635 8/20 0.46
CYP2C19 P33261 7/20 0.46
LMNA P02545 5/20 0.46
MAPT P10636 3/20 0.46
TSHR P16473 6/20 0.44
CLK4 Q9HAZ1 5/20 0.44
GSTO1 P78417 4/20 0.42
KDM4E B2RXH2 2/20 0.41
PDE10A Q9Y233 1/20 0.40
USP2 O75604 4/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 4/20 0.39
ALOX15 P16050 3/20 0.39
HSD17B10 Q99714 3/20 0.39
HIF1A Q16665 1/20 0.39
MEN1 O00255 2/20 0.39
CHEK2 O96017 1/20 0.37
ALK Q9UM73 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084878 0.90 CYP1A2 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084201 0.83 TSHR (0.44) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084108 0.80 TSHR (0.42) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084843 0.79 CYP1A2 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084636 0.79 PDE5A (0.44) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084405 0.79 GBA1 (0.50) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084262 0.79 CYP2D6 (0.50) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084482 0.79 TSHR (0.43) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084811 0.78 PDE5A (0.40) CYP1A2CYP3A4CYP2D6CYP2C19LMNA
SCHEMBL1084483 0.76 MAPT (0.51) LMNAMAPTTSHRKMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed